RT Journal Article
SR Electronic
T1 Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM)
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP P1216
VO 44
IS Suppl 58
A1 Belma Haliloglu
A1 Yasemin Gokdemir
A1 Zeynep Atay
A1 Saygin Abali
A1 Tulay Guran
A1 Fazilet Karakoc
A1 Refika Ersu
A1 Bulent Karadag
A1 Serap Turan
A1 Abdullah Bereket
YR 2014
UL http://erj.ersjournals.com/content/44/Suppl_58/P1216.abstract
AB Cystic Fibrosis Related Diabetes (CFRD) is one of the factors associated with increased mortality in CF. CGM has the potential to diagnose glucose abnormalities earlier than OGTT.Aim:To compare CGM vs standard OGTT in determining diabetes and other glucose abnormalities.Methods: 44 CF patients underwent OGTT followed by CGM for three days.The patients were classified according to OGTT categories and the CGM results.CGM results were grouped as hypoglycemia, hyperglycemia and both hypo and hyperglycemia.View this table:OGTT and CGM resultsResults: In 26 patients who had normal OGTT, CGM showed hyperglycemia in 7, both hypo-and hyperglycemia in 6, and hypoglycemia only in 1 patient. The frequency of hypoglycemia in OGTT was %13.6.Conclusion:CGM is a useful tool especially to determine hypoglycemia in CF patients which might be missed by OGTT. We suggest that CF patients should be evaluated by CGM especially if they are to be started/or on insulin treatment to detect and prevent hypoglycemia appropriately.